The RNA Leaders series explores into the scientific, clinical, and commercial advancements of RNA medicines, including RNAi, antisense, non-linear RNAs, RNA editing, and RNA targeting. It also covers mRNA therapy and vaccine manufacturing. This September, the 4th USA edition is back on the East Coast and will welcome over 350 attendees, expanding across modality-focused streams of oligos, mRNA and next-gen RNA covering, discovery & delivery innovation and clinical progression. Join biotech leaders, discovery innovators, delivery developers, manufacturers, big pharma, and investors at this exclusive forum for senior RNA experts driving the future of RNA-based therapies and technologies.
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.